MARY TANNER: Open Payments
NPI 1265212104 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,121 in 62 payments from 17 companies in 2025. Trend: 2023 $151 · 2024 $2,316 · 2025 $2,121
Food & beverage: $1,921Education: $200
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $388 |
| Novartis Pharmaceuticals Corporation | 6 | $379 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $268 |
| UCB, Inc. | 5 | $204 |
| Regeneron Healthcare Solutions, Inc. | 6 | $153 |
| Incyte Corporation | 3 | $146 |
| Janssen Scientific Affairs, LLC | 1 | $121 |
| Arcutis Biotherapeutics, Inc. | 2 | $111 |
| Janssen Biotech, Inc. | 2 | $111 |
| Botanix SB Inc | 3 | $59 |
Products named: DUPIXENT, TREMFYA, Bimzelx, COSENTYX, OPZELURA, Rhapsido, ILUMYA, Zoryve.
Industry payments across NC — which companies pay providers there.
